Research & Development

久热中文字幕日本www.在线中文字幕夜夜嚕2017最新在线王振华被批捕12天后 新城控股承认开始“甩卖”资产


  雲瑯制作的刀子跟徐夫人制作的匕首踫撞了幾次之後就變成了一把短鋸。   自此,秦宮多利器。久热中文字幕   此時的趙國已經于一年前為秦將王翦所破,惶惶如喪家之犬的徐夫人自縛入咸陽,願意終生為匠奴,換取一家存活。日本www.在线中文字幕   老虎走上繩梯,走的很穩,四條腿不斷地交替,很快就隱入對面的黑暗中了。   雲瑯不再猶豫,雙手一起用力,猛地把鐵刺刺進了大漢的後腦。夜夜嚕2017最新在线   “你他娘的居然耍賴抄近路!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo